David Chardin
Overview
Explore the profile of David Chardin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masse M, Chardin D, Tricarico P, Ferrari V, Martin N, Otto J, et al.
Eur J Nucl Med Mol Imaging
. 2024 Jun;
51(12):3696-3708.
PMID: 38896129
Aim: To determine the long-term prognosis of immune-related response profiles (pseudoprogression and dissociated response), not covered by conventional PERCIST criteria, in patients with non-small-cell lung cancer (NSCLC) treated with immune...
2.
Tricarico P, Chardin D, Martin N, Contu S, Hugonnet F, Otto J, et al.
J Immunother Cancer
. 2024 Apr;
12(4).
PMID: 38649279
Purpose: Because of atypical response imaging patterns in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs), new biomarkers are needed for a better monitoring...
3.
Chardin D, Jing L, Chazal-Ngo-Mai M, Guigonis J, Rigau V, Goze C, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069019
The aim of this study was to identify metabolomic signatures associated with the gliomagenesis pathway (-mutant or -wt) and tumor grade of diffuse gliomas (DGs) according to the 2021 WHO...
4.
Bailleux C, Chardin D, Guigonis J, Ferrero J, Chateau Y, Humbert O, et al.
Comput Struct Biotechnol J
. 2023 Nov;
21:5136-5143.
PMID: 37920813
Purpose: Meta-analyses failed to accurately identify patients with non-metastatic breast cancer who are likely to benefit from chemotherapy, and metabolomics could provide new answers. In our previous published work, patients...
5.
Bailleux C, Zwarthoed C, Evesque L, Baron D, Scouarnec C, Benezery K, et al.
Radiother Oncol
. 2023 Sep;
188:109905.
PMID: 37678620
Background And Purpose: The aim of our prospective study was to assess the prognostic value of 18F-FDG PET/CT performed two months post treatment for anal canal neoplasm. Population And Methods:...
6.
El Ouartassi A, Giordana C, Schiazza A, Chardin D, Darcourt J
Brain Imaging Behav
. 2023 Jul;
17(6):619-627.
PMID: 37474673
Purpose: First, to investigate the patterns of [F]-FDOPA positron emission tomography imaging in corticobasal syndrome using visual and semi-quantitative analysis and to compare them with patterns found in Parkinson's disease...
7.
Darcourt J, Chardin D, Bourg V, Gal J, Schiappa R, Blonski M, et al.
Eur J Nucl Med Mol Imaging
. 2023 Apr;
50(9):2727-2735.
PMID: 37086272
Background: Diagnostic value of 3,4-dihydroxy-6-[F]fluoro-L-phenylalanine ([F]FDOPA) PET in patients with suspected recurrent gliomas is recognised. We conducted a multicentre prospective study to assess its added value in the practical management...
8.
Bailleux C, Chardin D, Gal J, Guigonis J, Lindenthal S, Graslin F, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046602
Purpose: Identification of metabolomic biomarkers of high SBR grade in non-metastatic breast cancer. Methods: This retrospective bicentric metabolomic analysis included a training set ( = 51) and a validation set...
9.
Chardin D, Gille C, Pourcher T, Humbert O, Barlaud M
BMC Bioinformatics
. 2022 Sep;
23(1):361.
PMID: 36050631
Background: Presently, there is a wide variety of classification methods and deep neural network approaches in bioinformatics. Deep neural networks have proven their effectiveness for classification tasks, and have outperformed...
10.
Comte V, Schmutz H, Chardin D, Orlhac F, Darcourt J, Humbert O
Eur J Nucl Med Mol Imaging
. 2022 May;
49(11):3787-3796.
PMID: 35567626
Purpose: FDOPA PET shows good performance for the diagnosis of striatal dopaminergic denervation, making it a valuable tool for the differential diagnosis of Parkinsonism. Textural features are image biomarkers that...